Source: Eur Respir J 2013; 42: 885-887
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Cazzola Mario, Lopez-Campos Jose-Luis, Puente-Maestu Luis. The MABA approach: a new option to improve bronchodilator therapy. Eur Respir J 2013; 42: 885-887

Member's Comments

No comment yet.

Related content which might interest you: Do we have any alternative therapeutic option beyond antibiotics? Source: Postgraduate course 2021: PG7 - Postgraduate course : Emerging infectious diseases and antimicrobial resistance: diagnostics, treatments, vaccines and other preventive and/or therapeutic interventions Year: 2021 Inhaler preference comparing two alternative dual bronchodilator regimens Source: International Congress 2016 – Pulmonary drug delivery Year: 2016 A new combination therapeutic approach challenging the current dogma of using inhaled corticosteroids as maintenance only to control asthma Source: Eur Respir J 2006; 28: Suppl. 50, 666s Year: 2006 The concept of control in COPD: a new proposal for optimising therapy Source: Eur Respir J 2014; 44: 1072-1075 Year: 2014 Triple therapy versus single and dual long-acting bronchodilator therapy in COPD: a systematic review and meta-analysis Source: Eur Respir J, 52 (6) 1801586; 10.1183/13993003.01586-2018 Year: 2018 Triple therapy trials in COPD: a precision medicine opportunity Source: Eur Respir J, 52 (6) 1801848; 10.1183/13993003.01848-2018 Year: 2018 Macrolide combination therapy for hospitalised CAP patients? An individualised approach supported by machine learning Source: Eur Respir J, 54 (6) 1902111; 10.1183/13993003.02111-2019 Year: 2019 Single inhaler therapy with budesonide/formoterol in an allergic rat model: a new therapeutic strategy in asthma Source: Annual Congress 2004 - Further pharmacological and clinical evidence for using long-acting β-agonists with inhaled corticosteroids Year: 2004 Inhaled antibiotics: a new tool? Source: Annual Congress 2009 - Antibiotics and the lung Year: 2009 Antibiotics as immunomodulators: a potential pharmacologic approach for ARDS treatment Source: Eur Respir Rev, 30 (162) 210093; 10.1183/16000617.0093-2021 Year: 2021 Real-world effectiveness and cost-effectiveness of asthma step-up options: A UK comparison of extrafine hydrofluoroalkane-beclometasone and combination therapy Source: Annual Congress 2013 –Treatment and management of asthma in primary care Year: 2013 Proof of concept study to evaluate step down therapy with inhaled corticosteroid alone or additive therapy on surrogate inflammatory markers in asthma Source: Annual Congress 2010 - Pharmacological modulation of biomarkers and management Year: 2010 An inhaled “bifunctional” dual PDE3/4 inhibitor provides additional short-term improvements in lung function compared to existing classes of bronchodilator: implications for future treatment of COPD Source: Eur Respir J, 52 (5) 1801675; 10.1183/13993003.01675-2018 Year: 2018 A novel approach of using pharmaceutical pictogram for improving asthma inhaler techniques Source: International Congress 2018 – Pulmonary drug delivery: inhaler use, devices and technologies Year: 2018 Does combination therapy lead to better adherence in asthma? Source: Annual Congress 2010 - Combination therapy in asthma and COPD Year: 2010 Difficult-to-treat asthma : a multidimensional approach before considering targeted therapy Source: International Congress 2019 – Asthma: outcomes of clinical trials and cohorts Year: 2019 Which therapeutic options when CPAP fails?  Source: ERS Course 2017 - Paediatric noninvasive ventilation Year: 2017